Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy

被引：2
|
作者：
Bhui, Raj [1 ]
Spector, Andrew R. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Neurol, DUMC 3824, Durham, NC 27710 USA
来源：
NEUROMUSCULAR DISORDERS | 2020年 / 30卷 / 04期
关键词：
Pompe disease; Neuromuscular disease; Obstructive Sleep Apnea; Enzyme Replacement Therapy; MYASTHENIA-GRAVIS;
D O I：
10.1016/j.nmd.2020.02.004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Obstructive sleep apnea is a common complication of Pompe disease. Treatment for obstructive sleep apnea in patients with Pompe disease is similar to treatment in the general population, typically involving positive airway pressure therapy. We present a case in which a patient with late-onset Pompe disease was able to discontinue positive airway pressure therapy after treatment with enzyme replacement therapy for his Pompe disease. It is likely that an improvement in muscle tone from the enzyme replacement therapy was sufficient to eliminate his obstructive sleep apnea. Pharmacological therapies for obstructive sleep apnea are lacking but could apply to certain populations, such as Pompe disease. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [41] Enzyme replacement therapy in late-onset Pompe's disease: A three-year follow-up
    Winkel, LPF
    Van den Hout, JMP
    Kamphoven, JHJ
    Disseldorp, JAM
    Remmerswaal, M
    Arts, WFM
    Loonen, MCB
    Vulto, AG
    Van Doorn, PA
    De Jong, G
    Hop, W
    Smit, GPA
    Shapira, SK
    Boer, MA
    van Diggelen, OP
    Reuser, AJJ
    Van der Ploeg, AT
    ANNALS OF NEUROLOGY, 2004, 55 (04) : 495 - 502
  • [42] Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy
    Terzis, Gerasimos
    Dimopoulos, Filippos
    Papadimas, George K.
    Papadopoulos, Constantinos
    Spengos, Konstantinos
    Fatouros, Ioannis
    Kavouras, Stavros A.
    Manta, Panagiota
    MOLECULAR GENETICS AND METABOLISM, 2011, 104 (03) : 279 - 283
  • [43] Effect of Aerobic and Resistance Exercise Training on Late-Onset Pompe Disease Patients Receiving Enzyme Replacement Therapy
    Terzis, Gerasimos
    Papadimas, Georgios K.
    Dimopoulos, Filippos
    Papadopoulos, Costas
    Spengos, Konstantinos
    Fatouros, Ioannis
    Kavouras, Stavros
    Manta, Panagiota
    CLINICAL THERAPEUTICS, 2011, 33 : S40 - S40
  • [44] Long-term enzyme replacement therapy with alglucosidase alfa in children and adults with late-onset Pompe disease
    Theunissen, M.
    van Kooten, H.
    Harlaar, L.
    Ismailova, G.
    van den Hout, J.
    Rizopoulos, D.
    Boon, M.
    Brusse, E.
    van Doorn, P.
    van der Ploeg, A.
    van der Beek, N.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S150 - S150
  • [45] Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy
    Terzis, Gerasimos
    Krase, Argyro
    Papadimas, Giorgos
    Papadopoulos, Constantinos
    Kavouras, Stavros A.
    Manta, Panagiota
    MOLECULAR GENETICS AND METABOLISM, 2012, 107 (04) : 669 - 673
  • [46] Improvement of bone mineral density after enzyme replacement therapy in Chinese late-onset Pompe disease patients
    Sheng B.
    Chu Y.P.
    Wong W.T.
    Yau E.K.C.
    Chen S.P.L.
    Luk W.H.
    BMC Research Notes, 10 (1)
  • [47] Long-term effects of enzyme replacement therapy in an elderly cohort of late-onset Pompe disease patients
    Winkler, M.
    von Landenberg, C.
    Kuchenbecker, K.
    Reimann, J.
    Kornblum, C.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S50 - S50
  • [48] Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease
    Papadopoulos, Constantinos
    Orlikowsld, David
    Prigent, Helene
    Lacour, Arnaud
    Tard, Celine
    Furby, Alain
    Praline, Julien
    Sole, Guilhem
    Hogrel, Jean-Yves
    De Antonio, Marie
    Semplicini, Claudio
    Deibener-Kaminsky, Joelle
    Kaminsky, Pierre
    Eymard, Bruno
    Taouagh, Nadjib
    Perniconi, Barbara
    Hamroun, Dalil
    Laforet, Pascal
    Bassez, G.
    Bedat-Millet, A. -L.
    Behin, A.
    Eymard, B.
    Leonard -Louis, S.
    Stojkovic, T.
    Canal, A.
    Decostre, V.
    Bouhour, F.
    Boyer, F.
    Caillaud, C.
    Castaing, Y.
    Chapon, F.
    Cintas, P.
    Durieu, I.
    Echaniz-Laguna, A.
    Feasson, L.
    Ferrer, X.
    Froissart, R.
    Piraud, M.
    Germain, D.
    Benistan, K.
    Guffon-Fouilhoux, N.
    Journel, H.
    Labauge, P.
    Levy, A.
    Magot, A.
    Pereon, Y.
    Minot-Myhie, M-C
    Nadaj-Pakleza, A.
    Nathier, C.
    Pellegrini, N.
    MOLECULAR GENETICS AND METABOLISM, 2017, 122 (1-2) : 80 - 85
  • [49] Effects of enzyme replacement therapy on bone density in late onset Pompe disease
    Avanti, Mahima
    Martin, Angela
    Columbres, Rod Carlo
    Mozaffar, Tahseen
    Kimonis, Virginia
    MOLECULAR GENETICS AND METABOLISM, 2023, 140 (03)
  • [50] Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease
    Papadopoulos, C.
    Orlikowski, D.
    Prigent, H.
    Perniconi, B.
    Taouagh, N.
    Lacour, A.
    Tard, C.
    Furby, A.
    Praline, J.
    Sole, G.
    Semplicini, C.
    Kaminsky, P.
    Eymard, B.
    Hamroun, D.
    Laforet, P.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S109 - S110
12345